IGF1 and Alzheimer disease: T2DM and AD share some similar pathological findings, such as decreased insulin expression level, insulin-like growth factor 1 (IGF-1), insulin receptor substrate, and increased amyloid precursor protein (APP) expression level (de la Monte and Wands, 2005).